In a recent survey, the Science Advisory Board asked 500 of its U.S. members to share their views on the direct-to-consumer (DTC) testing industry, specifically in the context of the FDA's warning letter to 23andMe back in November of 2013. (You can see the results of that survey here.) What are your thoughts on the issue?

Poll Question:
Should the FDA further extend regulations regarding DTC testing technologies?

Yes, there is a significant lack of regulation in this area

Yes, but only for a subset of these products

No, it would have a negative effect on these innovations

No, consumers should have access to as much personalized medical info as possible

Previous articleBRAIN Storm: Panel Urges $4.5B More for Research Through FY 2026
Next articleAntitope to Develop Cell Line for Baylor’s Cancer Vaccine